DomenicaMarieRubinoMD
Endocrinology • Arlington, VADiabetes, Lipid Metabolism, Obesity
Washington Center for Weight Management & Research, Inc.
Dr. Rubino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2800 S Shirlington Rd
Ste 500
Arlington, VA 22206Phone+1 703-807-0037Fax+1 703-807-0038
Summary
- Dr. Domenica Rubino is an endocrinologist in Arlington, VA and is affiliated with multiple hospitals in the area, including Inova Fairfax Hospital and Virginia Hospital Center. She received her medical degree from Rush Medical College and has been in practice 28 years. She specializes in diabetes, lipid metabolism, and obesity and is experienced in obesity and obesity-related disorders, behavioral counseling, binge-eating disorder, clinical research, and medical weight loss.
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1992 - 1997
Rush University Medical CenterResidency, Internal Medicine, 1989 - 1992
Rush Medical College of Rush University Medical CenterClass of 1989
Certifications & Licensure
VA State Medical License 1999 - 2026
MD State Medical License 1992 - 2025
DC State Medical License 1999 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Obesity Medicine Obesity Medicine
Clinical Trials
- Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity Start of enrollment: 2008 Jul 01
- Impact of the Use of FeelWell™ Compression Garment on Individuals With a BMI ≥35 Start of enrollment: 2019 Feb 13
- The Effect of Epitomee Capsule on Body Weight in Patients With Overweight and Obesity Start of enrollment: 2020 Sep 15
Roles: Contact
Publications & Presentations
PubMed
- Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 ...Domenica M Rubino, Sue D Pedersen, Lisa Connery, Dachuang Cao, Farai Chigutsa
Diabetes, Obesity & Metabolism. 2025-01-09 - 4 citationsEffect of semaglutide 2.4 mg on physical functioning and weight- and health-related quality of life in adults with overweight or obesity: Patient-reported outcomes fro...Domenica Rubino, Jakob B Bjorner, Naveen Rathor, Arya M Sharma, Lisa von Huth Smith
Diabetes, Obesity & Metabolism. 2024-07-01 - 3 citationsEfficacy and safety of semaglutide 2.4 mg by race and ethnicity: A post hoc analysis of three randomized controlled trials.Domenica Rubino, Hanna Angelene, Anthony Fabricatore, Jamy Ard
Obesity. 2024-07-01
Press Mentions
Trending Weight Loss Drugs Surge in Popularity and Become Harder to FindJanuary 20th, 2023- Trending Weight Loss Drugs Surge in Popularity and Become Harder to FindJanuary 20th, 2023
- New Drug Could Change Way Obesity Is TreatedFebruary 25th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
External Links
- Washington Center for Weight Management and Researchhttp://www.wtmgmt.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
